| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/18/2011 | US20110200557 New 2-amidothiadiazole derivatives |
| 08/18/2011 | US20110200556 Chemoprevention of head and neck squamous cell carcinomas |
| 08/18/2011 | US20110200555 Conjugates of hydroxyalkyl starch and a protein |
| 08/18/2011 | US20110200554 Therapeutic agent for hepatitis c |
| 08/18/2011 | US20110200553 Compounds and methods for the treatment or prevention of flavivirus infections |
| 08/18/2011 | US20110200552 Cytokine design |
| 08/18/2011 | US20110200541 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 08/18/2011 | US20110200533 Compounds for the diagnosis of diseases associated with vcam expression |
| 08/18/2011 | US20110200528 Cyclized ngr peptide compounds, compositions, and methods of their use |
| 08/18/2011 | US20110200524 Vector for use in medicine |
| 08/18/2011 | CA2789679A1 Modified adam disintegrin domain polypeptides and uses thereof |
| 08/18/2011 | CA2789331A1 Secondary structure stabilized nmda receptor modulators and uses thereof |
| 08/18/2011 | CA2789055A1 Orally administrable pharmaceutical pellet of epidermal growth factor |
| 08/18/2011 | CA2787990A1 Nucleic acid complexes |
| 08/18/2011 | CA2787727A1 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases |
| 08/17/2011 | EP2357478A2 Diagnosis of disease |
| 08/17/2011 | EP2357238A2 Compositions and methods for regulation of tumor necrosis factor-alpha |
| 08/17/2011 | EP2357200A1 Human antibodies that bind human TNFalpha |
| 08/17/2011 | EP2357198A1 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 08/17/2011 | EP2357195A1 Growth factor complexes and modulation of cell migration and growth |
| 08/17/2011 | EP2357194A1 Growth factor complexes and modulation of cell migration and growth |
| 08/17/2011 | EP2357193A1 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 08/17/2011 | EP2357192A1 Human endokine alpha and methods of use |
| 08/17/2011 | EP2357191A2 Cyclic antimicrobial peptides |
| 08/17/2011 | EP2357190A2 Cyclic antimicrobial peptides |
| 08/17/2011 | EP2357187A1 Molecules with extended half-lives, compositions and uses thereof |
| 08/17/2011 | EP2357008A1 Albumin fusion proteins |
| 08/17/2011 | EP2357005A1 Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas |
| 08/17/2011 | EP2357004A1 NRG-2 nucleic acid molecules, polypeptides and diagnostic and therapeutical methods |
| 08/17/2011 | EP2357002A1 Nucleic acid molecules and polypeptides for immune modulation |
| 08/17/2011 | EP2356998A1 A pharmaceutical composition for treatment of thrombosis-related diseases comprising a fragment of prolactin (PRL)-growth hormone (GH) - placental lactogen (PL)-family protein |
| 08/17/2011 | EP2356997A1 Compositions and methods for lipo modeling |
| 08/17/2011 | EP2356996A1 Treatment for Alzeimer's disease |
| 08/17/2011 | EP2356995A2 Process of preparation of formulations of the peptide Angiotensin-(1-7) and its analogues, agonists and antagonists using cyclodextrins, liposomes and biodegradable polymers and/or mixtures and products thereof |
| 08/17/2011 | EP2356994A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 08/17/2011 | EP2356990A2 Liposome treatment of viral infections |
| 08/17/2011 | EP2356446A1 Therapeutic and diagnostic methods relating to cancer stem cells |
| 08/17/2011 | EP2356238A2 Nurr1 interacting protein (nuip) |
| 08/17/2011 | EP2356225A1 GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS |
| 08/17/2011 | EP2356222A2 Foxp3 natural killer t-cells and the treatment of immune related diseases |
| 08/17/2011 | EP2356139A2 Ligation of stapled polypeptides |
| 08/17/2011 | EP2355852A1 Chemically modified cell-penetrating peptides for improved delivery of gene modulating compounds |
| 08/17/2011 | EP2355846A2 Immunogenic escherichia coli heat stable enterotoxin |
| 08/17/2011 | EP2355839A2 Compositions and methods of use for soluble thrombomodulin variants |
| 08/17/2011 | EP2355838A2 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof |
| 08/17/2011 | EP2355837A1 Cycloundecadepsipeptide compounds and use of said compounds as a medicament |
| 08/17/2011 | EP2355836A2 Compositions and methods for promoting vascular barrier function and treating pulmonary fibrosis |
| 08/17/2011 | EP2355829A1 Combination of insulin with triazine derivatives and its use for treating diabetes |
| 08/17/2011 | EP2178556B1 Protein c for use in maintaining hemostasis |
| 08/17/2011 | EP2158214B1 Glucagon analogues |
| 08/17/2011 | EP2127668B1 Glycosyltransferase for treating Inflammatory Bowel Disease |
| 08/17/2011 | EP2089425B1 Anti-angiogenic compounds |
| 08/17/2011 | EP1885750B1 Bone morphogenetic protein 4 and osteogenic devices and pharmaceutical products containing thereof |
| 08/17/2011 | EP1879911B1 Dye conjugates of template-fixed peptidomimetics |
| 08/17/2011 | EP1725223B1 Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases |
| 08/17/2011 | EP1575531B1 Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 08/17/2011 | EP1571970B1 Diagnosis and monitoring of diseases |
| 08/17/2011 | EP1558273B1 Treatment and prevention of pulmonary conditions |
| 08/17/2011 | EP1491553B1 Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumours |
| 08/17/2011 | EP1456419B1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 08/17/2011 | EP1402253B1 A process for the isolation of a major harmful oxidant from cigarette smoke |
| 08/17/2011 | EP1328547B1 Identification and modification of immunodominant epitopes in polypeptides |
| 08/17/2011 | CN1929854B A diffenrentiation- or regeneration-inducing agent for alveoli |
| 08/17/2011 | CN1917898B Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections |
| 08/17/2011 | CN1898261B Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof |
| 08/17/2011 | CN1897812B Glycopegylated granulocyte colony stimulating factor |
| 08/17/2011 | CN1867348B Orally administered small peptides synergized statin activity |
| 08/17/2011 | CN1822765B Delivery of compounds with rehydrated blood cells |
| 08/17/2011 | CN1787741B Methods and compositions for the prevention and treatment of sepsis |
| 08/17/2011 | CN1715926B Use of neuregulin mutant |
| 08/17/2011 | CN1637416B Labelled growth hormone secretagogue and its synthesis method and uses |
| 08/17/2011 | CN102159285A Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors |
| 08/17/2011 | CN102159241A Tapasin augmentation for enhanced immune response |
| 08/17/2011 | CN102159237A Compositions and methods for treatment during non-acute periods following cns neurological injury |
| 08/17/2011 | CN102159236A Therapeutic dosing of neuregulin or subsequence thereof for treatment or prophylaxis of heart failure |
| 08/17/2011 | CN102159235A Compositions comprising mg29 nucleic acids, polypeptides and associated methods of use |
| 08/17/2011 | CN102159234A Treatment of rheumatoid arthritis with mammal beta defensins |
| 08/17/2011 | CN102159233A Treatment of inflammatory bowel diseases with mammal beta defensins |
| 08/17/2011 | CN102159232A Treatment of inflammatory diseases with mammal beta defensins |
| 08/17/2011 | CN102159231A Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome |
| 08/17/2011 | CN102159230A Modified bovine g-csf polypeptides and their uses |
| 08/17/2011 | CN102159229A Pyrazalone derivative formulations |
| 08/17/2011 | CN102159223A Treating or preventing rotavirus infection |
| 08/17/2011 | CN102159192A Preparation method of biodegradable micro-particles containing drugs |
| 08/17/2011 | CN102154482A Application of calcium activated chloride channels ANO1/TMEM16A in diagnosis and treatment of prostate cancer |
| 08/17/2011 | CN102154355A Recombinant immunotoxin CCL25-PE38 gene and preparation method as well as application thereof |
| 08/17/2011 | CN102154307A Method for preparing recombinant chicken beta-interferon and application thereof |
| 08/17/2011 | CN102154301A Preparation and application of conotoxin striatus S21a in South China Sea |
| 08/17/2011 | CN102154300A Conus lividus neurotoxin and coding sequence and use thereof |
| 08/17/2011 | CN102154299A Preparation method of oral medicament active peptide from shark liver for treating diabetes |
| 08/17/2011 | CN102154259A Preparation method and use of genetic engineering preparation for dissolving blood platelet thrombi |
| 08/17/2011 | CN102154253A Micro plasminogen mutant with function of inhibiting platelet aggregation and preparation method and application thereof |
| 08/17/2011 | CN102154238A Lipase capable of effectively reducing cholesterol level and blood fat level of human body and application thereof |
| 08/17/2011 | CN102154237A Lipase capable of reducing cholesterol and blood fat levels in bodies of animals and use thereof |
| 08/17/2011 | CN102153657A IL-24-TAT PTD fusion protein and construction method and application thereof |
| 08/17/2011 | CN102153655A Targeted anti-tumor recombinant protein and preparation method thereof |
| 08/17/2011 | CN102153653A Fusion protein of tumor blood vessel targeted polypeptide and tissue factor and preparation method thereof |
| 08/17/2011 | CN102153652A Expression method and application of fusion protein |
| 08/17/2011 | CN102153642A Application of protein with function of inhibiting growth of scar fibroblast |
| 08/17/2011 | CN102153641A Preparation method and application of mutain of human insulin-like growth factor binding protein 7 (IGFBP7) |